PIAS3 and breast carcinoma: Oncogenic miRNA-9 and miRNA-181a inhibit PIAS3 in IL-6high breast cancer to promote expansion of early-stage myeloid-derived suppressor cells, resulting in suppression of T-cell immunity [79].